Instrument Inactif

Gouvernance Peregrine Pharmaceuticals Nasdaq

US7136613046

Produits pharmaceutiques

Comité Exécutif: Peregrine Pharmaceuticals

Dirigeant

Fonctions occupéesDepuis

Kenneth Bilenberg

Chief Executive Officer	15/09/2025
President	15/09/2025

Mark Ziebell

62 ans

General Counsel	20/06/2012
Corporate Secretary	01/07/2012

Nick Ferguson

Chief Tech/Sci/R&D Officer

01/01/1999

Richard Richieri

61 ans

Chief Operating Officer

09/10/2019

Richard McAvoy

Director of Finance/CFO

01/06/2026

David Stewart

Chief Tech/Sci/R&D Officer

01/11/2025

Maria Ebro Andreasen

Human Resources Officer

01/05/2026

Composition du Conseil d'Administration: Peregrine Pharmaceuticals

Administrateur	ComitésDepuis

Anciens Dirigeants et Administrateurs: Peregrine Pharmaceuticals

Insider

Fonctions occupées

DepuisJusqu'au

Daniel Hart

Comptroller/Controller/Auditor	01/08/2018	-
Director/Board Member	05/02/2025	01/06/2026
Director of Finance/CFO	01/08/2018	01/06/2026

Michael Alston

Corporate Officer/Principal

01/01/2019

01/01/2026

Nicholas Green

Chief Executive Officer	30/07/2020	15/09/2025
President	30/07/2020	15/09/2025

Richard Hancock

Director/Board Member	27/11/2017	05/02/2025
Chief Executive Officer	08/05/2019	30/07/2020
President	08/05/2019	30/07/2020

Gregory Sargen

Director/Board Member	27/11/2017	05/02/2025
Independent Dir/Board Member	27/11/2017	05/02/2025

Joseph Carleone

Director/Board Member	27/11/2017	-
Chairman	-	05/02/2025
Independent Dir/Board Member	27/11/2017	05/02/2025

Catherine Mackey

Director/Board Member	25/07/2019	05/02/2025
Independent Dir/Board Member	25/07/2019	05/02/2025

Esther Alegria

Director/Board Member	28/06/2021	05/02/2025
Independent Dir/Board Member	28/06/2021	05/02/2025

Jeanne A. Thoma

Director/Board Member	03/12/2020	05/02/2025
Independent Dir/Board Member	03/12/2020	05/02/2025

Oksana Lukash

Corporate Officer/Principal

16/11/2022

Lorna Larson

Human Resources Officer

01/01/2018

01/06/2022

Matthew Kwietniak

Corporate Officer/Principal

07/10/2021

Mark Bamforth

Director/Board Member	01/10/2017	08/07/2021
Independent Dir/Board Member	01/10/2017	08/07/2021

Patrick Walsh

Director/Board Member	24/10/2017	01/03/2021
Independent Dir/Board Member	24/10/2017	01/03/2021

Tracy Kinjerski

Chief Operating Officer	01/11/2017	09/10/2019
Corporate Officer/Principal	09/10/2019	08/01/2020

Timothy Compton

Corporate Officer/Principal

08/01/2020

Joel McComb

Director/Board Member	27/11/2017	22/07/2019
Independent Dir/Board Member	27/11/2017	22/07/2019

Roger J. Lias

Director/Board Member	01/09/2017	07/05/2019
Chief Executive Officer	10/12/2017	07/05/2019
President	26/12/2017	07/05/2019

Michael Faughnan

Corporate Officer/Principal

01/07/2018

01/05/2019

Stephen Hedberg

Comptroller/Controller/Auditor	11/07/2018	-
Director of Finance/CFO	11/07/2018	17/07/2018

Paul Lytle

Director of Finance/CFO

01/03/1997

24/05/2018

Joseph S. Shan

Chief Tech/Sci/R&D Officer	01/01/2003	31/12/2017
General Counsel	01/01/2003	31/12/2017

Steven King

Director/Board Member	11/07/2011	27/11/2017
Chief Executive Officer	01/01/2003	27/11/2017
Chief Operating Officer	01/01/2002	01/01/2003
Chief Tech/Sci/R&D Officer	01/01/1997	01/01/2002
President	11/07/2011	27/11/2017

Carlton Johnson

Director/Board Member	01/11/1999	22/10/2010
Chairman	22/10/2010	27/11/2017
Independent Dir/Board Member	31/10/2011	27/11/2017

David H. Pohl

Director/Board Member	01/10/2004	27/11/2017
Independent Dir/Board Member	31/10/2011	27/11/2017

Eric S. Swartz

Director/Board Member	01/01/1999	27/11/2017
Independent Dir/Board Member	31/10/2011	27/11/2017

Stephen Worsley

Corporate Officer/Principal

10/12/2013

01/10/2017

Jeff Hutchins

Corporate Officer/Principal

01/09/2012

01/12/2016

Christopher S. Keenan

Public Communications Contact

01/06/2015

Jeffrey L. Masten

Corporate Officer/Principal

02/06/2011

20/02/2014

Vladimir Evilevitch

Chief Tech/Sci/R&D Officer

31/10/2011

Kerstin B. Menander

Corporate Officer/Principal

11/03/2011

Truc Le

Chief Operating Officer

01/01/2009

01/01/2011

Robert Garnick

General Counsel

20/10/2009

Thomas A. Waltz

Chairman

01/01/2004

01/12/2008

Christopher Eso

Corporate Officer/Principal

25/03/2010

Shay Tabani

Corporate Officer/Principal

26/10/2009

F. David King

Corporate Officer/Principal

01/10/2005

Shelley P. M. Fussey

Corporate Officer/Principal

01/02/2005

John L. Quick

Corporate Officer/Principal

01/01/2004

K. A. Ajit-Simh

Corporate Officer/Principal

02/01/2002

Lon H. Stone

Chief Executive Officer

01/02/1982

01/01/1997

Thomas Doyle

Comptroller/Controller/Auditor

Jay Carlson

Investor Relations Contact	-	-
Public Communications Contact	-	-

Terrence Chew

Chief Tech/Sci/R&D Officer	-	-
General Counsel	-	-

Marvin R. Garovoy

Chief Tech/Sci/R&D Officer

01/09/2010

Jennifer Anderson

Public Communications Contact

01/09/2010

Amy Figueroa

Investor Relations Contact	31/10/2011	-
Public Communications Contact	25/08/2010	-

Edward J. Legere

President

Gene Yoshioka

Corporate Officer/Principal

Linda Donaldson

Public Communications Contact

10/09/2009

Robert McNeil

Chairman

Mary J. Boyd

Corporate Officer/Principal

Krista Mallory

Public Communications Contact

Clive R. Taylor

Director/Board Member

David House

Comptroller/Controller/Auditor

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	6
Femme	2

Dont comité exécutif

Homme	6
Femme	1

Dont Administrateurs

Homme	0
Femme	0

EAvid Bioservices, Inc. est une organisation spécialisée dans le développement et la fabrication sous contrat (CDMO) qui se consacre au développement et à la fabrication de produits biologiques conformément aux bonnes pratiques de fabrication actuelles (CGMP). La société propose une gamme complète de services de développement de procédés, de fabrication clinique et commerciale conforme aux CGMP destinés aux secteurs de la biotechnologie et de la biopharmacie. Ses services comprennent la fabrication clinique et commerciale de substances médicamenteuses conforme aux CGMP, le conditionnement en vrac, les essais de libération et de stabilité, ainsi que l'assistance pour les dossiers réglementaires. Pour les programmes en phase précoce, la société propose diverses activités de développement de procédés, notamment le développement de lignées cellulaires, le développement et l’optimisation des étapes en amont et en aval, ainsi que le développement, les essais et la caractérisation de méthodes analytiques. L’étendue de ses services va des projets de développement de procédés autonomes aux programmes complets de développement et de fabrication jusqu’à la commercialisation. Les produits biologiques commerciaux qu’elle fabrique sont distribués dans plus de 90 pays.

Employés

Secteur

Produits pharmaceutiques

Plus d'informations sur la société